已收盤 09-19 16:00:00 美东时间
-0.020
-1.68%
安进的双抗产品管线在今年有了不少新变化:1月,终止CD3/BCMA双抗AMG 420的临床开发;同月,出于商业决定终止了CD3/CLDN18.2双抗AMG 9...
09-02 07:48
Analysts have been eager to weigh in on the Healthcare sector with new ratings ...
08-22 21:20
CytomX Therapeutics - Sales Agreement Prospectus Covering Offering of up to $58...
08-10 04:09
CytomX Therapeutics Inc Files for Mixed Shelf of up to $250 Mln – SEC Filing
08-10 04:08
CytomX Therapeutics Inc : BMO Cuts Target Price to $3.56 From $3.59
08-09 19:45
CytomX Therapeutics Q2 Cash & Investments USD 137.2 Million
08-09 04:10
CytomX Therapeutics Q2 Net Income USD -6.534 Million
08-09 04:10
H.C. Wainwright analyst Mitchell Kapoor reiterated a Hold rating on CytomX Ther...
06-27 18:17
CytomX Therapeutics (NASDAQ:CTMX) on Monday announced the promotion of Chris Ogden to Chief Financial Officer effective June 15, 2024. Ogden joined CytomX in August 2021 as Vice President, Finance and...
06-18 04:31